FDA Whistleblower Blasts New Merck Painkiller

Law360, New York (September 13, 2006, 12:00 AM EDT) -- The same U.S. Food and Drug Administrator that railed against the agency’s actions during the rise and fall of Merck & Co. Inc.’s blockbuster arthritis drug Vioxx made headlines again on Wednesday when he criticized the drug company’s experimental painkiller, Arcoxia, saying it may carry the same risk of heart attacks and strokes as Vioxx.

David J. Graham, a physician in the FDA's Office of Drug Safety, said in an editorial posted on the Journal of the American Medical Association's Web site this week that clinical...
To view the full article, register now.